SCHEMBL21851005

SCHEMBL21851005

CCN(Nc1ccccccccc1)c1ccccccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
NOX1 Q9Y5S8 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GLA P06280 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
NR3C2 P08235 1/20 0.40
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036650 1.00 CRHBP (0.49) CRHBPCRHR2CYP1A2CYP3A4CYP2C9
SCHEMBL9346505 0.77 ICMT (0.47) CRHBPCRHR2CYP1A2CYP3A4CYP2C9
SCHEMBL8978987 0.77 ALDH1A1 (0.43) CYP3A4MEN1KMT2ARAB9ANPC1
SCHEMBL27693295 0.77 CRHBP (0.70) CRHBPCRHR2CYP1A2CYP3A4CYP2C9
SCHEMBL7982311 0.76 ALDH1A1 (0.44) MEN1KMT2ARAB9ANPC1NOX1
SCHEMBL29137131 0.76 ALDH1A1 (0.48) CRHBPCRHR2MEN1KMT2ARAB9A
SCHEMBL28313149 0.75 CXCR2 (0.44) CRHBPCRHR2CYP1A2CYP3A4CYP2C9
SCHEMBL9281094 0.75 KDM4E (0.38) CRHBPCRHR2CYP1A2CYP3A4CYP2C9
SCHEMBL50189 0.75 L3MBTL1 (0.52) MEN1KMT2ARAB9ANPC1NOX1
Iodide SCHEMBL31634395 0.75 L3MBTL1 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021159372-A1 USE OF JAK INHIBITORS IN PREPARATION OF DRUGS FOR TREATING JAK KINASE-RELATED DISEASES 珠海联邦制药股份有限公司 2021-08-19 WO disclosed
WO-2020063855-A1 QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF 南京明德新药研发有限公司 2020-04-02 WO disclosed